retatrutide study news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide efficacy vs. Tirzepatide: The

The therapeutic strategy remains focused on treating the root cause excess adiposity and metabolic dysregulation rather than the inflammatory consequence

LL-37 enhances keratinocyte migration, modulates inflammation, and promotes angiogenesis, all key to effective healing

5 Diabetes technologies, including continuous glucose monitors, are increasingly becoming a part of routine clinical management, particularly for type 1 diabetes, for which they are subsidised under the National Diabetes Services Scheme

Falsified and unauthorised imitation products containing GLP-1 active substances When GLP-1 products first began to attract public interest, there were repeated cases of products being falsified by label swapping

Iron, magnesium and several other important micronutrients can fall short

Both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)